Literature DB >> 12216761

Three-dimensional gray scale volume rendering of the liver: preliminary clinical experience.

Hui-Xiong Xu1, Ming-De Lu, Yu-Qing Zhou, Qing-Ping Zhang, Xiao-Yu Yin, Xiao-Yan Xie, Li Liu.   

Abstract

OBJECTIVE: To investigate the potential clinical usefulness of three-dimensional gray scale volume rendering in the liver.
METHODS: Sixty-two patients were enrolled in the study and categorized into 2 groups: group I with ascites and group II without. Two types of volume-rendering modes, i.e., surface and transparent, were used to obtain the three-dimensional images. The data were reviewed to identify the differences between two- and three-dimensional images of the liver in each subject.
RESULTS: In group I, three-dimensional sonography was superior to two-dimensional sonography in terms of surface features, edges, overall three-dimensional impression, image clarity, and structural relationships. However, it seemed that three-dimensional sonography in the surface mode was inferior to two-dimensional sonography in showing intrahepatic structures, because it had decreased resolution. In group II, three-dimensional sonography was superior to two-dimensional sonography with respect to the continuity of intrahepatic vessels, overall three-dimensional impression of the vessels, image clarity, and the relationship between lesions and neighboring vessels. However, the resolution of the lesions was decreased in 7 cases of hepatocellular carcinoma.
CONCLUSIONS: Our experience suggests that three-dimensional gray scale volume rendering of the liver provides more diagnostic information than two-dimensional sonography; however, further studies are needed to evaluate its clinical importance.

Entities:  

Mesh:

Year:  2002        PMID: 12216761     DOI: 10.7863/jum.2002.21.9.961

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  1 in total

1.  Era of diagnostic and interventional ultrasound.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2011-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.